Compare CYTK & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | NNN |
|---|---|---|
| Founded | 1997 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.5B |
| IPO Year | 2004 | 1995 |
| Metric | CYTK | NNN |
|---|---|---|
| Price | $59.89 | $44.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 18 | 6 |
| Target Price | ★ $87.56 | $43.67 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | $13,368,000.00 | ★ $926,213,000.00 |
| Revenue This Year | $9.79 | $5.70 |
| Revenue Next Year | $302.66 | $5.21 |
| P/E Ratio | ★ N/A | $21.78 |
| Revenue Growth | N/A | ★ 6.55 |
| 52 Week Low | $29.31 | $35.80 |
| 52 Week High | $70.98 | $46.03 |
| Indicator | CYTK | NNN |
|---|---|---|
| Relative Strength Index (RSI) | 40.30 | 56.12 |
| Support Level | $59.25 | $40.70 |
| Resistance Level | $65.93 | $45.75 |
| Average True Range (ATR) | 2.65 | 0.70 |
| MACD | -0.32 | -0.11 |
| Stochastic Oscillator | 3.98 | 39.81 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.